The Precision Peptide Genetic Test from PlexusDx ($99 add-on or $298 standalone) reveals predispositions in peptide genetic pathways relevant to GLP-1 medications
In some embodiments, the formulations or compositions described herein have a pH between about 5 and about 8, or between about 6 and about 7, or between about 6.5 and about 7, or between about 5.5 and about 7.5, or between about 7.1 and about 7.7, and have a concentration of active pharmaceutical ingredient between about 1 and about 100 mM
Diagnosis of NAFLD The underdiagnosis and undertreatment of non-alcoholic fatty liver disease (NAFLD) are largely attributed to limited healthcare resources, lack of clinical awareness, suboptimal diagnostic tools, and the absence of effective pharmacotherapies
This LASSS-HGF strategy could be adaptable to aging 32,41,42,68,69,70 and several disorders and diseases that show the generation and accumulation of nitrated HGF and particular nitrated proteins at specific sites, including cardiovascular damage 71,72 , chronic obstructive pulmonary disease (COPD) 73 , colon and lung cancer 74,75,76 , Alzheimers and Parkinsons diseases 44 46 ,77,78
&srotate=0)
